SCHEMBL21568692

SCHEMBL21568692

CC(=O)Nc1nc2ccc(C#N)cc2s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 12/20 1.00
▸ PIK3CG P48736 3/20 0.69
▸ NPC1 O15118 3/20 0.64
▸ RAB9A P51151 3/20 0.64
▸ CYP1A2 P05177 2/20 0.64
▸ CYP3A4 P08684 2/20 0.64
▸ CYP2C19 P33261 2/20 0.64
▸ CYP2C9 P11712 1/20 0.64
▸ FSCN1 Q16658 1/20 0.64
▸ PDPK1 O15530 1/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ HTT P42858 1/20 0.61
▸ PIK3CA P42336 1/20 0.60
▸ PIK3CB P42338 1/20 0.60
▸ PI4KB Q9UBF8 1/20 0.60
▸ GSK3B P49841 1/20 0.59
▸ ADORA1 P30542 1/20 0.58
▸ LDHA P00338 1/20 0.56
▸ STAT1 P42224 1/20 0.55
▸ CSNK1D P48730 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21568049 0.86 DYRK1A (0.76) DYRK1APIK3CGNPC1RAB9ACYP1A2
SCHEMBL6067966 0.86 DYRK1A (0.76) DYRK1APIK3CGNPC1RAB9ACYP1A2
SCHEMBL13718453 0.85 DYRK1A (0.74) DYRK1APIK3CGNPC1RAB9ASMN1; SMN2
SCHEMBL6068126 0.83 DYRK1A (0.71) DYRK1APIK3CGNPC1RAB9ASMN1; SMN2
SCHEMBL6067971 0.82 DYRK1A (0.69) DYRK1APIK3CGNPC1RAB9ACYP1A2
SCHEMBL23256895 0.81 DYRK1A (0.68) DYRK1ANPC1RAB9ASMN1; SMN2GSK3B
SCHEMBL23256870 0.81 DYRK1A (0.70) DYRK1ANPC1RAB9ASMN1; SMN2HTT
SCHEMBL21568954 0.80 DYRK1A (0.66) DYRK1APIK3CGNPC1RAB9ASMN1; SMN2
SCHEMBL3409205 0.80 DYRK1A (0.67) DYRK1APIK3CGNPC1RAB9ACYP1A2
SCHEMBL23256883 0.80 DYRK1A (0.66) DYRK1ANPC1RAB9ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217509-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER HB THERAPEUTICS INC. (US) 2019-11-14 — — WO disclosed
Send feedback